Clinical trial
Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)
NCT01988571
Study timeline
Study start (actual)2014-02-01Date precision: day
Registry last updated2022-01-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerverified · MONDO: breast cancer
Lymphomaverified · MONDO: lymphoma
Interventions
AtorvastatinDRUG · verified · RxNorm: atorvastatin
PlaceboDRUG
Sponsors & collaborators
Wake Forest University Health Scienceslead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Winston-SalemNorth Carolina, United States3GreenvilleSouth Carolina, United States3ChicagoIllinois, United States2ColumbusOhio, United States2Washington D.C.District of Columbia, United States2CharlotteNorth Carolina, United States2RichmondVirginia, United States2WichitaKansas, United States2Saint PaulMinnesota, United States2AshevilleNorth Carolina, United States2BostonMassachusetts, United States1Los AngelesCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01988571 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.